AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Caelyx Cancer Treatment Receives Approval in Canada.(for women with ovarian cancer)
2001 FEB 22 - (NewsRx.com) -- A drug treatment developed at the University of Alberta (U of A) to improve the quality of life for women with ovarian cancer has been approved for use in Canada.
"This approval means these women now have a chance of therapy that appears to be useful," said Dr. Terry Allen, a U of A pharmacology professor who developed the treatment. "Every year, 2,509 women in Canada are diagnosed with ovarian cancer and of that number 1,500 will die. Those are the women we are targeting, the ones who would die or are at the advanced stages of the disease."
Schering Canada announced that Health Canada has approved Caelyx, the brand name for liposomal doxorubicin, for women who have failed standard first-line ovarian cancer therapy.
Allen's research, based on "Stealth" technology, uses a targeted delivery system to help evade recognition by the body's immune system. The Stealth liposomes disguise themselves as water, allowing the drug to stay circulating in the body for a longer period of time, increasing their chances of reaching the targeted tumor sites. As a result, the debilitating side effects associated with other chemotherapies are reduced, while the effectiveness of the drug is increased.
...- Elizabeth Manley joins the fight against Ovarian Cancer as National...
- News wire article from: The America's Intelligence Wire April 22, 2009 700+ words
...Walk of Hope in support of Ovarian Cancer Canada to increase awareness and...raises crucial funds for Ovarian Cancer Canada - the country's only national...for more than a few weeks, Ovarian Cancer Canada urges her to tell a physician...
- ALZA'S CAELYX(R) Approved in Canada for Treatment of Advanced Ovarian Cancer.
- Press release article from: PR Newswire January 30, 2001 700+ words
...approximately 2,500 women in Canada are diagnosed with ovarian cancer. 1,400 Canadian...of cancer deaths in Canada. Ovarian cancer is the second most...treatments available in Canada for late-stage ovarian cancer are known to have...
- Schering Canada Inc. Announces Marketing Approval Of Caelyx(R) for Advanced...
- Press release article from: PR Newswire January 30, 2001 700+ words
...ovarian cancer." Ovarian cancer is frequently referred...will be diagnosed with ovarian cancer this year. Of these...rate of 60 percent. Ovarian cancer ranks as the fifth...cancer for women in Canada, and among gynecologic...
- IDM Announces Approval for Phase III Clinical Trial For Ovarian Cancer in...
- Press release article from: PR Newswire October 30, 2001 700+ words
...for the treatment of ovarian cancer using IDM's Cell Drug...into North America and Canada. Everyone at IDM and...patients with Stage III ovarian cancer. The aim is to prolong...for the treatment of ovarian cancer.
- Media advisory - Major U.S.-Canada partnership announcement advances...
- Press release article from: PR Newswire April 3, 2006 700+ words
...British Columbia, Canada will announce a major step forward in ovarian cancer research and early detection, for Canada, the United States...Centre Susan Sorbie, ovarian cancer patient Where...Victoria B.C., Canada When: Wednesday...
- IDM ANNOUNCES APPROVAL FOR PHASE III CLINICAL TRIAL FOR OVARIAN CANCER IN...
- Press release article from: PR Newswire October 30, 2001 700+ words
...clinical trials for the treatment of ovarian cancer using IDM's Cell DrugTM known...clinical trial into North America and Canada. Everyone at IDM and especially...targets patients with Stage III ovarian cancer. The aim is to prolong remission...
- PRESS RELEASE: Alza's Caelyx approved in Canada for treatment of advanced...
- News wire article from: Chemical Business Newsbase February 5, 2001 700+ words
...hydrochloride) for the treatment of advanced ovarian cancer in women who have failed first-line...Stealth liposomal technology. Schering Canada Inc, a wholly owned subsidiary of Schering-Plough Corp, will market Caelyx in Canada. Alza Corp, headquartered in Mountain...
- Taxol approved as treatment for ovarian cancer in U.S. and Canada. (U.S. Food...
- Newspaper article from: Cancer Weekly January 4, 1993 700+ words
...Administration (FDA) as a treatment for ovarian cancer. But the FDA said the drug can only...Some 21,000 women are diagnosed with ovarian cancer each year in the U.S., and many...information on Taxol and other treatments for ovarian cancer may call NCI's Cancer Information...
- PRESS RELEASE: Schering Canada Inc announces marketing approval of Caelyx for...
- News wire article from: Chemical Business Newsbase February 5, 2001 700+ words
Schering Canada Inc announced that Caelyx (pegylated...Therapeutic Products Programme of Health Canada for the treatment of advanced ovarian...reaching the targeted tumour sites. Schering Canada Inc is a wholly owned subsidiary of Schering...
- Ovarian Cancer Patients Sought for Worldwide Study; Study of Nearly 700 Women...
- Press release article from: PR Newswire May 8, 1998 700+ words
...women with advanced ovarian cancer to participate in a...the United States, Canada, Europe, the Middle...Russia and Australia. Ovarian Cancer and Multidrug Resistance...patients with advanced ovarian cancer respond initially to...
Source: HighBeam Research, Caelyx Cancer Treatment Receives Approval in Canada.(for women with...